Controller Medications in the Management of Bronchial Asthma
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to know the effect of another controller medication add on to
the inhaled corticosteroid and long acting β2 agonist on clinical symptom, lung function and
compliance in patients of moderate to severe persistent bronchial asthma.